FOX Business Flash top headlines for June 30
Check out what’s clicking on FoxBusiness.com.
Pfizer and BioNTech SE said Wednesday that they had inked a $3.2 billion agreement with the U.S. government for 105 million doses of their COVID-19 vaccine.
The deal includes new versions of the shots, and they would be delivered by the fall, pending a decision by the Food and Drug Administration (FDA).
Federal officials say the deal includes the option to purchase a total of 300 million vaccine doses.
This comes as Pfizer said Thursday that it is seeking full approval for its oral COVID antiviral treatment Paxlovid by the FDA.
BIONTECH, PFIZER TO START TESTING UNIVERSAL VACCINE FOR CORONAVIRUSES